Ubs Asset Management Americas Inc Artivion, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 318,966 shares of AORT stock, worth $13.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,966
Previous 313,394
1.78%
Holding current value
$13.8 Million
Previous $7.7 Million
28.77%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$286 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$128 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$121 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$120 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$100 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.74B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...